MS-SRM enables absolute linear quantification of protein expression levels in tumor cells with HER2 expression levels greater than five orders of magnitude and simultaneous quantification of multiple protein biomarkers throughout the treatment process (33). This evidence concerns the gene ERBB2 and neoplasm.